Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical R. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN100500643C details a novel 3-step synthesis of 3,4,5-tribenzyloxyaniline using Hofmann rearrangement, offering high purity and reduced environmental impact for pharmaceutical intermediates.
Patent CN104592163A enables cost-effective chiral pyrrolidine synthesis. Enhances supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN117327042B details a high-yield synthesis method for antiviral intermediates. This process offers significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN103159672A details a novel tropicamide preparation using phenyl ethyl malonate, offering cost reduction in pharmaceutical manufacturing and improved supply chain reliability.
Patent CN109810065B reveals a high-yield two-step synthesis for Elagolix, offering significant cost reduction and purity improvements for pharmaceutical manufacturing supply chains.
Novel green synthesis of ethyl 2-acetyl-3-nitromethylene-5-methyl-hexanoate using recyclable DES solvent, offering high yield and cost efficiency.
Patent CN110803994B reveals a green DES-based route for pregabalin intermediates. Discover how this technology enables cost reduction in API manufacturing and reliable supply.
Advanced synthesis of Tiaprofenic Acid via patent CN102432591B. Delivers high-purity NSAID intermediates with optimized cost reduction in API manufacturing and supply reliability.
Patent CN112707901A reveals a cost-effective resolution method for moxifloxacin side chains using gulonic acid, offering >98% ee and simplified manufacturing for reliable API intermediate supply.
Patent CN110803993B reveals a green DES-based synthesis for pregabalin intermediates, offering high yields, recyclable solvents, and scalable mechanochemical processing for cost-effective manufacturing.
Patent CN111285860B reveals novel indole-triazole hybrids with potent antibacterial activity, offering reliable agrochemical intermediate supply and streamlined manufacturing processes.
Novel patent CN115160172B details high-yield iopromide synthesis. Offers cost reduction and supply chain reliability for contrast agent manufacturing.
Advanced crystallization method boosts Oxiracetam purity to 98%. Offers cost-effective scalable solutions for pharmaceutical intermediate supply chains globally.
Patent CN116478087B enables high-purity sodium picosulfate intermediate production with improved yield and supply chain reliability for pharmaceutical manufacturing.
Patent CN102731316B reveals a safer sulfonyl protection route for 1,2-N,N'-dimethylcyclohexanediamine, offering high purity and industrial scalability for pharmaceutical supply chains.
Patent CN103059048A details a novel BSA-mediated silylation method for Cefpiramide acid, offering superior purity and homogeneous reaction conditions for pharmaceutical manufacturing.
Optimized synthesis patent CN104672281B ensures high purity and yield. Reliable supply chain for antiviral API manufacturing with cost-effective processes.
Advanced monochiral metal-organic framework technology enables high-efficiency chiral separation and photoinduction, offering cost-effective solutions for pharmaceutical manufacturing.
Novel synthetic route for 25-hydroxyvitamin D3 offering high yield and scalable manufacturing for pharmaceutical supply chains and global procurement.
Novel synthesis route using cheap phytosterol reduces costs and improves yield for steroid drug intermediates ensuring supply chain stability.